LncRNA TTN-AS1 exacerbates extracellular matrix accumulation via miR-493-3p/FOXP2 axis in diabetic nephropathy

被引：0
作者：
Lin Jia
Wenzhe Wang
Hui Liu
Fan Zhu
Yunfang Huang
机构：
[1] Huazhong University of Science and Technology,Department of Nephrology, The Central Hospital of Wuhan, Tongji Medical College
来源：
Journal of Genetics | / 102卷
关键词：
TTN-AS1; miR-493-3p; FOXP2; ECM accumulation; diabetic nephropathy.;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Diabetic nephropathy (DN), a common cause of chronic renal failure and end-stage renal disease, leads to a high mortality. However, the role of TTN-AS1 in extracellular matrix (ECM) accumulation during DN remains unclear. In our study, TTN-AS1 exhibited high expression in high glucose-treated mesangial cells, and TTN-AS1 silencing alleviated high glucose-induced ECM accumulation in mesangial cells. Additionally, animal study revealed that TTN-AS1 was upregulated in renal tissues of DN rats, and TTN-AS1 knockdown mitigated renal injury of DN rats. Mechanistically, TTN-AS1 was validated to bind to miR-493-3p, and miR-493-3p targeted forkhead box P2 (FOXP2) 3′untranslated region in mesangial cells. TTN-AS1 interacted with miR-493-3p to upregulate FOXP2 in vitro and in vivo. Moreover, FOXP2 overexpression counteracted the effects of TTN-AS1 silencing on the ECM accumulation. In conclusion, TTN-AS1 exacerbated ECM accumulation via the miR‐493-3p/FOXP2 axis during DN development. This research may provide a potential new direction for DN treatment.
引用
收藏
相关论文
共 177 条
[11]  
Dimmeler S(2018)MiR-34a regulates axonal growth of dorsal root ganglia neurons by targeting FOXP2 and VAT1 in postnatal and adult mouse Mol Neurobiol. 55 9089-1500
[12]  
Choudhury D(2004)Human FOX gene family (Review) Int J Oncol. 25 1495-407
[13]  
Tuncel M(2018)Functional classification and experimental dissection of long noncoding RNAs Cell. 172 393-408
[14]  
Levi M(2001)Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method Methods. 25 402-220
[15]  
Dashti S(2018)RNA therapeutics in cardiovascular disease Circ Res. 123 205-1312
[16]  
Taherian-Esfahani Z(2022)The role of long noncoding RNA MALAT1 in diabetic polyneuropathy and the impact of its silencing in the dorsal root ganglion by a DNA/RNA heteroduplex oligonucleotide Diabetes. 71 1299-260
[17]  
Kholghi-Oskooei V(2016)Inhibition of the processing of miR-25 by HIPK2-phosphorylated-MeCP2 induces NOX4 in early diabetic nephropathy Sci Rep. 6 38789-469
[18]  
Noroozi R(2018)Long noncoding RNA HOTAIR promotes renal cell carcinoma malignancy through alpha-2, 8-sialyltransferase 4 by sponging microRNA-124 Cell Prolif. 51 e12507-480
[19]  
Arsang-Jang S(2022)The sponging effect of a lncRNA on a miRNA contributes to diabetic nephropathy Mol Ther Nucleic Acids. 28 259-2207
[20]  
Ghafouri-Fard S(2012)Inhibiting microRNA-192 ameliorates renal fibrosis in diabetic nephropathy J Am Soc Nephrol. 23 458-222
12345678910